Could probiotics help tame fatty liver?

NCT ID NCT04555434

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three different probiotics (Pediococcus pentosaceus, Lactobacillus lactis, and Lactobacillus helveticus) in 89 adults with non-alcoholic fatty liver disease. Participants took probiotic capsules or a placebo daily for 8 weeks, along with a standard liver supplement. Researchers measured liver function, body changes, and gut bacteria to see if the probiotics improved liver health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Probiotics (Pediococcus pentosaceus KID7, Lactobacillus lactis CKDB001, Lactobacillus helveticus CKDB001)
What this could lead to
If successful, this could point toward a simple, safe dietary supplement to help manage fatty liver disease.
What could go wrong
This is an early-phase trial with only 89 participants and an 8-week duration. Results may not apply to everyone, and the effect may be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hallym University Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwon-do, 200-704, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.